Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder
NCT03558919
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
81
Enrollment
OTHER
Sponsor class
Conditions
Overactive Bladder
Interventions
DRUG:
Mirabegron 25mg
DRUG:
Solifenacin Succinate 5 MG
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh